Average Co-Inventor Count = 8.87
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (43 from 410 patents)
2. Janssen Pharmaceutica Nv (4 from 2,076 patents)
3. Janssen Pharmaceuticals, Inc. (2 from 159 patents)
4. Biocerox Products B.v. (2 from 3 patents)
5. New York University (1 from 1,624 patents)
6. Centocor, Inc. (1 from 144 patents)
7. Centocor Ortho Biotech Inc. (1 from 31 patents)
51 patents:
1. 12460001 - Proteins comprising CD3 antigen binding domains and uses thereof
2. 12234280 - Anti-PHF-tau antibodies and uses thereof
3. 12161716 - Anti-IL-23 antibodies, compositions, methods and uses
4. 12084501 - Proteins comprising CD3 antigen binding domains and uses thereof
5. 12077585 - Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses
6. 12071466 - Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof
7. 11787875 - Materials and methods for improved single chain variable fragments
8. 11746161 - Antibodies that specifically bind PD-1 and methods of use
9. 11236155 - Antibodies to pyroglutamate amyloid-β and uses thereof
10. 11185584 - Anti-IL-23 antibodies, compositions, methods and uses
11. 10995149 - Antibodies that specifically bind PD-1 and methods of use
12. 10844122 - Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
13. 10781246 - Compositions and methods for anti-staphylococcal biologic agents
14. 10759854 - Interferon alpha and omega antibody antagonists
15. 10633435 - Anti-PHF-tau antibodies and uses thereof